Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03845504 · ClinicalTrials.gov registry record · NA
iTBS in Refractory Pediatric Depression
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03845504: Clinical Trial NA study, sponsored by Stanford University.
NCT03845504 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03845504, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This work will mark the first step in understanding the neural targets for rTMS in youth with difficult to treat depressive symptoms, creating benchmarks for optimizing the safety and efficacy of rTMS for pediatric populations through precision targeting, and encourage funding applications for larger sham- controlled randomized clinical studies.
Interventions
- DEVICE Intermittent Theta Burst Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-11-19 |
| Est. Completion | 2019-10-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03845504
The ClinicalTrials.gov registry entry for NCT03845504 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intermittent Theta Burst Stimulation is the first listed.
NCT03845504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03845504 about?
NCT03845504 is a clinical study titled "iTBS in Refractory Pediatric Depression". This work will mark the first step in understanding the neural targets for rTMS in youth with difficult to treat depressive symptoms, creating benchmarks for optimizing the safety and efficacy of rTMS for pediatric populations through precision targeting, and encourage funding applications for large...
What is the current status of trial NCT03845504?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2018-11-19. Estimated completion is 2019-10-09.
What interventions are being tested in trial NCT03845504?
The interventions under investigation include: Intermittent Theta Burst Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03845504?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.